All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC0372 | Human anti-esxB T cell receptor (TCR001), pCDTCR1 | Mycobacterium tuberculosis | TCR001 | Human | TAAQAAVVRFQEAAN | HLA-DQA1*01:02 | Lentiviral vector | |
TCR-YC0373 | Human anti-esxB T cell receptor (TCR004), pCDTCR1 | Mycobacterium tuberculosis | TCR004 | Human | TAAQAAVVRFQEAAN | HLA-DQA1*01:02 | Lentiviral vector | |
TCR-YC0374 | Human anti-esxB T cell receptor (TCR012), pCDTCR1 | Mycobacterium tuberculosis | TCR012 | Human | TAAQAAVVRFQEAAN | HLA-DQA1*01:02 | Lentiviral vector | |
TCR-YC0375 | Human anti-esxB T cell receptor ((TCR087)-1), pCDTCR1 | Mycobacterium tuberculosis | TCR087 | Human | AAVVRFQEAANKQKQ | HLA-DRB5*01:01 | Lentiviral vector | |
TCR-YC0376 | Human anti-esxB T cell receptor ((TCR087)-2), pCDTCR1 | Mycobacterium tuberculosis | TCR087 | Human | QAAVVRFQEAANKQK | HLA-DRB5*01:01 | Lentiviral vector | |
TCR-YC0377 | Human anti-esxB T cell receptor ((TCR088)-1), pCDTCR1 | Mycobacterium tuberculosis | TCR088 | Human | AAVVRFQEAANKQKQ | HLA-DRB5*01:01 | Lentiviral vector | |
TCR-YC0378 | Human anti-esxB T cell receptor ((TCR088)-2), pCDTCR1 | Mycobacterium tuberculosis | TCR088 | Human | QAAVVRFQEAANKQK | HLA-DRB5*01:01 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION